Target intelligence / Profile preview

Zinc finger protein 598 (ZNF598)

Target
ZNF598
Molecular classification
E3 ubiquitin ligase (RING-type), Zinc finger protein (C2H2-type), RNA-binding protein, Ribosome quality control factor
01

Overview

Zinc finger protein 598 (ZNF598) is an E3 ubiquitin-protein ligase and zinc finger protein that plays a central role in ribosome-associated quality control (RQC), a fundamental cellular pathway active when ribosomes stall during translation. ZNF598 specifically recognizes collided ribosomes and, upon binding, ubiquitinates certain 40S ribosomal subunit proteins (notably RPS10 and RPS20), which signals for the recruitment of ribosome-splitting complexes leading to nascent peptide degradation and ribosome recycling. This protein is also important for the surveillance of prematurely polyadenylated mRNAs and translation repression via interactions with the 4EHP-GYF2 complex. ZNF598 is involved in RNA binding and contains both a RING domain characteristic of E3 ligases and C2H2-type zinc finger motifs typical for nucleic acid interaction. It has documented disease associations with frontotemporal dementia, amyotrophic lateral sclerosis, and neuromuscular disorders[1][2][3]. No approved drugs are known to target ZNF598 directly, but its key translational surveillance and stress response functions have implicated it as a pharmacological and research target.

Other names
E3 ubiquitin-protein ligase ZNF598FLJ00086HEL2ZNF598 {ECO:0000303|PubMed:28132843, ECO:0000312|HGNC:HGNC:28079}
02

Mechanism of action

Drugs or molecules targeting ZNF598 would be expected to modulate its E3 ubiquitin ligase activity, especially on ribosomal proteins during ribosome stalling, or alter its interaction with the 4EHP-GYF2 translation repression complex.

03

Biological functions

Ribosome-associated quality control (RQC)Ribosome collision recognitionUbiquitination of ribosomal proteins (RPS10, RPS20, RPS3A)Translation repressionRegulation of mRNA stability (via no-go decay)Regulation of interferon-stimulated gene expression
04

Disease associations

Neurodegenerative disease (e.g., frontotemporal dementia and/or amyotrophic lateral sclerosis 7)Neuromuscular diseasePotential roles in viral infection and cancer (via E3 ligase regulation of translation and immunity)
05

Safety considerations

Perturbing ZNF598 could disrupt global protein synthesis quality control, potentially leading to the accumulation of faulty proteins.Interference may have neuronal or muscular side effects due to known disease associations.

Beyond the preview

Go deeper on Zinc finger protein 598 (ZNF598).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zinc finger protein 598 (ZNF598).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call